Electrocardiogram, plasma catecholamines and lipids, and their modification by oxyprenolol when speaking before an audience.
D000284:Administration, Oral; D000328:Adult; D002395:Catecholamines / Q000097:blood*; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000503:physiopathology; D004562:Electrocardiography; D004644:Emotions / Q000187:drug effects*; D004837:Epinephrine / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D010096:Oxprenolol / Q000008:administration & dosage / Q000494:pharmacology*; D010919:Placebos; D011187:Posture; D014280:Triglycerides / Q000097:blood
D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D010919:Placebos; D014280:Triglycerides; D010096:Oxprenolol; D002784:Cholesterol; D009638:Norepinephrine; D004837:Epinephrine